{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:23:43Z","timestamp":1790029423888,"version":"4.0.1"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Bronchiectasis (not related to cystic fibrosis) is a chronic lung disease caused by a range of etiologies but characterized by abnormal airway dilatation, recurrent respiratory symptoms, impaired quality of life and reduced life expectancy. Patients typically experience episodes of chronic wet cough and recurrent pulmonary exacerbations requiring hospitalization. Early diagnosis and management of childhood bronchiectasis are essential to prevent respiratory decline, optimize quality of life, minimize pulmonary exacerbations, and potentially reverse bronchial disease. Disease monitoring potentially allows for (1) the early detection of acute exacerbations, facilitating timely intervention, (2) tracking the rate of disease progression for prognostic purposes, and (3) quantifying the response to therapies. This narrative review article will discuss methods for monitoring disease progression in children with bronchiectasis, including lung imaging, respiratory function, patient-reported outcomes, respiratory exacerbations, sputum biomarkers, and nutritional outcomes.<\/jats:p>","DOI":"10.3389\/fped.2022.1010016","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:15:40Z","timestamp":1663308940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Monitoring disease progression in childhood bronchiectasis"],"prefix":"10.3389","volume":"10","author":[{"given":"Kathryn A.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"00122","DOI":"10.1183\/23120541.00122-2021","article-title":"Clinical and research priorities for children and young people with bronchiectasis: an international roadmap","volume":"7","author":"Chang","year":"2021","journal-title":"ERJ Open Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"190161","DOI":"10.1183\/16000617.0161-2019","article-title":"Measuring airway clearance outcomes in bronchiectasis: a review","volume":"29","author":"Franks","year":"2020","journal-title":"Eur Respir Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1183\/09031936.00122508","article-title":"Assessing response to treatment of exacerbations of bronchiectasis in adults","volume":"33","author":"Murray","year":"2009","journal-title":"Eur Respir J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bmjebm-2018-110893","article-title":"Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies","volume":"23","author":"Abu Dabrh","year":"2018","journal-title":"BMJ Evid Based Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"24287","DOI":"10.1038\/s41598-021-03778-8","article-title":"Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.98.11020462","article-title":"Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method","volume":"11","author":"Chang","year":"1998","journal-title":"Eur Respir J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2002990","DOI":"10.1183\/13993003.02990-2020","article-title":"European respiratory society guidelines for the management of children and adolescents with bronchiectasis","volume":"58","author":"Chang","year":"2021","journal-title":"Eur Respir J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1259\/bjr\/96908158","article-title":"Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis","volume":"83","author":"Hill","year":"2010","journal-title":"Br J Radiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2214\/AJR.05.0723","article-title":"Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis","volume":"187","author":"Dodd","year":"2006","journal-title":"AJR Am J Roentgenol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1378\/chest.10-1763","article-title":"Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: need to redefine bronchial dilatation","volume":"139","author":"Kapur","year":"2011","journal-title":"Chest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0720-048X(02)00122-5","article-title":"Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs","volume":"47","author":"Gaillard","year":"2003","journal-title":"Eur J Radiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/thx.2003.011577","article-title":"The need to redefine non-cystic fibrosis bronchiectasis in childhood","volume":"59","author":"Eastham","year":"2004","journal-title":"Thorax."},{"key":"B13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1378\/chest.130.2.480","article-title":"Lung structure abnormalities, but normal lung function in pediatric bronchiectasis","volume":"130","author":"Santamaria","year":"2006","journal-title":"Chest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1164\/rccm.201508-1574LE","article-title":"Reply: excess risk of cancer from computed tomography scan is small but not so low as to be incalculable","volume":"192","author":"Rosenow","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1513\/AnnalsATS.201603-203OC","article-title":"Ultrashort echo-time magnetic resonance imaging is a sensitive method for the evaluation of early cystic fibrosis lung disease","volume":"13","author":"Roach","year":"2016","journal-title":"Ann Am Thorac Soc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/mrm.26096","article-title":"Matrix pencil decomposition of time-resolved proton MRI for robust and improved assessment of pulmonary ventilation and perfusion","volume":"77","author":"Bauman","year":"2017","journal-title":"Magn Reson Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1164\/rccm.201604-0893OC","article-title":"Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis","volume":"195","author":"Stahl","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielputz","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1513\/AnnalsATS.201712-967OC","article-title":"Structural and functional lung impairment in primary ciliary dyskinesia. Assessment with magnetic resonance imaging and multiple breath washout in comparison to spirometry","volume":"15","author":"Nyilas","year":"2018","journal-title":"Ann Am Thorac Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"210173","DOI":"10.1183\/16000617.0173-2021","article-title":"State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the \u201cimaging management of cystic fibrosis\u201d (maestro) consortium","volume":"31","author":"Ciet","year":"2022","journal-title":"Eur Respir Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1002\/ppul.23537","article-title":"Early detection and sensitive monitoring of cf lung disease: prospects of improved and safer imaging","volume":"51","author":"Mall","year":"2016","journal-title":"Pediatr Pulmonol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1016\/S2214-109X(19)30070-1","article-title":"Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study","volume":"7","author":"Duong","year":"2019","journal-title":"Lancet Glob Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/15412550902766934","article-title":"Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood","volume":"6","author":"King","year":"2009","journal-title":"COPD."},{"key":"B24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/thx.2005.047332","article-title":"Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis","volume":"61","author":"Twiss","year":"2006","journal-title":"Thorax."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.chest.2020.03.084","article-title":"Pediatric patients of outreach specialist queensland clinics have lung function improvement comparable to that of tertiary pediatric patients","volume":"158","author":"Collaro","year":"2020","journal-title":"Chest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00408-020-00332-7","article-title":"Culturally appropriate outreach specialist respiratory medical care improves the lung function of children in regional and remote Queensland","volume":"198","author":"Collaro","year":"2020","journal-title":"Lung."},{"key":"B27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/thx.2008.100958","article-title":"Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function","volume":"64","author":"Bastardo","year":"2009","journal-title":"Thorax."},{"key":"B28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1378\/chest.09-2932","article-title":"Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?","volume":"138","author":"Kapur","year":"2010","journal-title":"Chest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ppul.24696","article-title":"A decade on: follow-up findings of indigenous children with bronchiectasis","volume":"55","author":"McCallum","year":"2020","journal-title":"Pediatr Pulmonol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(18)31554-X","article-title":"Bronchiectasis in children: diagnosis and treatment","volume":"392","author":"Chang","year":"2018","journal-title":"Lancet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/jpc.14817","article-title":"Respiratory health profile of indigenous australian children and young adults","volume":"56","author":"Blake","year":"2020","journal-title":"J Paediatr Child Health."},{"key":"B33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1164\/rccm.201507-1409OC","article-title":"Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis","volume":"193","author":"Ramsey","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jcf.2019.02.007","article-title":"Abnormal preschool lung clearance index (LCI) reflects clinical status and predicts lower spirometry later in childhood in cystic fibrosis","volume":"18","author":"Hardaker","year":"2019","journal-title":"J Cyst Fibros."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1513\/AnnalsATS.201611-935OC","article-title":"Multiple-breath washout outcomes are sensitive to inflammation and infection in children with cystic fibrosis","volume":"14","author":"Ramsey","year":"2017","journal-title":"Ann Am Thorac Soc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.201608-1754OC","article-title":"Lumacaftor\/ivacaftor in patients aged 6-11 years with cystic fibrosis and homozygous for F508del-Cftr","volume":"195","author":"Milla","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1513\/AnnalsATS.202006-584OC","article-title":"Multiple breath washout outcome measures in adults with bronchiectasis","volume":"19","author":"O'Neill","year":"2022","journal-title":"Ann Am Thorac Soc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1164\/rccm.201310-1747OC","article-title":"Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis","volume":"189","author":"Rowan","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201402-0206LE","article-title":"Lung clearance index in primary ciliary dyskinesia and bronchiectasis","volume":"189","author":"Irving","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1183\/13993003.00152-2015","article-title":"The reproducibility and responsiveness of the lung clearance index in bronchiectasis","volume":"46","author":"Grillo","year":"2015","journal-title":"Eur Respir J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/07853890.2021.1900594","article-title":"The contribution of pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study","volume":"53","author":"Wang","year":"2021","journal-title":"Ann Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"106728","DOI":"10.1016\/j.rmed.2021.106728","article-title":"Bronchiectasis and inhaled tobramycin: a literature review","volume":"192","author":"Elborn","year":"2022","journal-title":"Respir Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/imj.15210","article-title":"Meta-analysis of efficacy and safety of inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis patients","volume":"51","author":"Wang","year":"2021","journal-title":"Intern Med J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/antibiotics11020275","article-title":"Safety and efficacy of devices delivering inhaled antibiotics among adults with non-cystic fibrosis bronchiectasis: a systematic review and a network meta-analysis","volume":"11","author":"Tejada","year":"2022","journal-title":"Antibiotics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/jpc.15899","article-title":"Randomised controlled trial of nebulised gentamicin in children with bronchiectasis","volume":"58","author":"Twiss","year":"2022","journal-title":"J Paediatr Child Health."},{"key":"B46","doi-asserted-by":"publisher","first-page":"CD013254","DOI":"10.1002\/14651858.CD013254.pub2","article-title":"Intermittent prophylactic antibiotics for bronchiectasis","volume":"1","author":"Spencer","year":"2022","journal-title":"Cochrane Database Syst Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1800238","DOI":"10.1183\/13993003.00238-2018","article-title":"The clinical significance of oropharyngeal cultures in young children with cystic fibrosis","volume":"51","author":"Breuer","year":"2018","journal-title":"Eur Respir J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ppul.23636","article-title":"Induced sputum to detect lung pathogens in young children with cystic fibrosis","volume":"52","author":"D'Sylva","year":"2017","journal-title":"Pediatr Pulmonol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S2213-2600(18)30183-8","article-title":"Cough swabs less useful but induced sputum very useful in symptomatic older children with cystic fibrosis","volume":"6","author":"Schultz","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S2213-2600(18)30171-1","article-title":"The Cf-Sputum Induction Trial (CF-Spit) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial","volume":"6","author":"Ronchetti","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1365-2710.2008.00951.x","article-title":"Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis","volume":"33","author":"Guran","year":"2008","journal-title":"J Clin Pharm Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ppul.21550","article-title":"Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis","volume":"47","author":"Kapur","year":"2012","journal-title":"Pediatr Pulmonol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ppul.22544","article-title":"Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis","volume":"48","author":"Pizzutto","year":"2013","journal-title":"Pediatr Pulmonol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0129517","DOI":"10.1371\/journal.pone.0129517","article-title":"High Pulmonary Levels of Il-6 and Il-1beta in children with chronic suppurative lung disease are associated with low systemic IFN-gamma production in response to non-typeable haemophilus influenzae","volume":"10","author":"Pizzutto","year":"2015","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/thorax.57.1.15","article-title":"Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors","volume":"57","author":"Angrill","year":"2002","journal-title":"Thorax."},{"key":"B56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1378\/chest.121.1.81","article-title":"Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease","volume":"121","author":"Loukides","year":"2002","journal-title":"Chest."},{"key":"B57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ppul.20587","article-title":"Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis","volume":"42","author":"Guran","year":"2007","journal-title":"Pediatr Pulmonol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1155\/2011\/920465","article-title":"Persistent sputum cellularity and neutrophils may predict bronchiectasis","volume":"18","author":"Drost","year":"2011","journal-title":"Can Respir J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1034\/j.1399-3003.2000.16f13.x","article-title":"Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis","volume":"16","author":"Wark","year":"2000","journal-title":"Eur Respir J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2100025","DOI":"10.1183\/13993003.00025-2021","article-title":"Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis","volume":"58","author":"McLeese","year":"2021","journal-title":"Eur Respir J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1378\/chest.10-1476","article-title":"Minimally important change in a parent-proxy quality-of-life questionnaire for pediatric chronic cough","volume":"139","author":"Newcombe","year":"2011","journal-title":"Chest."},{"key":"B65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/thx.2009.133868","article-title":"Validation of a parent-proxy quality of life questionnaire for paediatric chronic cough (Pc-Qol)","volume":"65","author":"Newcombe","year":"2010","journal-title":"Thorax."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","article-title":"Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (Best-2): a multicentre, double-blind, non-inferiority, randomised controlled trial","volume":"392","author":"Goyal","year":"2018","journal-title":"Lancet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.chest.2020.06.073","article-title":"Recognition and management of protracted bacterial bronchitis in australian aboriginal children: a knowledge translation approach","volume":"159","author":"Laird","year":"2021","journal-title":"Chest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ppul.21518","article-title":"Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis","volume":"47","author":"Kapur","year":"2012","journal-title":"Pediatr Pulmonol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e104236","DOI":"10.1371\/journal.pone.0104236","article-title":"children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable haemophilus influenzae","volume":"9","author":"Pizzutto","year":"2014","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (bronchiectasis intervention study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","article-title":"Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (best-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial","volume":"7","author":"Goyal","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2101657","DOI":"10.1183\/13993003.01657-2021","article-title":"Children's bronchiectasis education advocacy and research network (child-bear-net): an ERS clinical research collaboration on improving outcomes of children and adolescents with bronchiectasis","volume":"58","author":"Chang","year":"2021","journal-title":"Eur Respir J."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1010016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:15:43Z","timestamp":1663308943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1010016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":72,"alternative-id":["10.3389\/fped.2022.1010016"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1010016","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"1010016"}}